Translate
Subscribe to Blog via Email
Ronny Allan
The NET Detectives is an awareness post.
Detecting NETs
In general, it’s probably true to say that Neuroendocrine Tumours (NETs) are difficult to diagnose. Some are more complex than others and their heterogeneity is legendary. In many cases, they can be quiet, and imaging is key in finding them if they are big enough to be seen. As most primary care facilities (e.g. General Practitioner (GP) offices) don’t have a range of imaging devices on site, referrals are often necessary to investigate more. I don’t believe it’s right to say this referral is a misdiagnosis, it’s just another stage in the investigation, another hunt for clues.
The number of cases where incidental diagnoses occur is fairly significant in certain types. I have no numbers but appendiceal NETs are a good analogy. Symptoms are experienced, primary care probably suspects appendicitis but as I said above, they do not have the tools on site to check. Therefore, a scan is ordered at a local hospital suitability equipped; and the NET is found incidentally. The thought that the primary care check should have diagnosed the appendiceal NET on the spot is fanciful because the reaction to certain symptoms presented often leads to a further test to narrow things down. Moreover, only around 1% of appendectomies turn out to be a NET. As the results are normally sent from secondary care back to primary care, technically the diagnosis has been successful, incidentally or not. This happens in many illnesses, not just NETs.
According to GP Notebook, up to 50% of patients who present in general practice, a firm diagnosis based on pathology may not be possible. Where diagnosis at this level cannot be achieved, working diagnoses are often expressed at a lower level in terms of the patient’s symptoms, signs or problems. A diagnosis is the current statement of probability about the cause of an illness rather than of absolute certainty. As such it must be regarded as provisional unless more evidence is available or until there is no longer a need for a diagnosis at all. Provisional diagnoses should not always be considered as misdiagnoses.
But even detectives specialise, a general practitioner’s job is difficult given the possibility of 10,000 people arriving at their desks with 10,000 different illnesses. However, experience over many years, improves their detective skills. But in many ways and for many reasons, awareness and NET detective skills at secondary care are more likely to solve cases quicker.

Hormonal Syndromes and NET
NET hormonal syndromes can be more difficult to detect. Firstly, it must be remembered that not everyone will present with a hormonal syndrome, in fact most NETs are non-functional, another myth. In a chicken and egg sense, there must be tumours if there is a hormonal syndrome. So, once again, imaging can be a case solver. Pre-diagnostic pathology can also help as a major clue – in my own case, a low hemoglobin score triggered my eventual diagnosis (BOOM!).
This area is where we really need “NET detectives”. However, even a regular detective can trigger a diagnosis as proven by my own experience. But NET is a very experienced ‘health criminal’ and will ‘pick your pocket’ without anyone knowing. Blood tests are normally a clue but as the symptoms are so general, they are so ‘day to day’, getting the primary care to carry out a specialist tests for NET can prove difficult. You just can’t screen the entire population for a NET because they present with day-to-day symptoms – it’s just not practical, nor is it achievable. For example, there are significantly more people with asthma, diarrhea, IBS, heart issues, flushing, heartburn, and blood pressure issues, than there are NET diagnoses. Again, this is where we need a proper awareness and more NET detectives, and it may need more than one interview to get a lead or a breakthrough, ergo someone with NET may need to see several people as part of the analysis.

Sometimes, a doctor (or a nurse) thinks outside the box, sometimes a doctor (or a nurse) thinks like a detective. But simple awareness can potentially make a good detective and can be key to solving cases. Awareness is not just standing outside the shopping centre shaking a bucket, making doctors and nurses aware of NETs can make a real difference. It’s just not easy to do when you consider the above.
Awareness
One of the key advantages of no longer being a rare disease, is that more doctors are now interested. More doctors now know more about this disease, more people in the general population know about the disease. The other issue is ‘blanket statements’ being made about NET despite its widely known heterogeneity.
Social media is undoubtedly playing a part. Think back prior to 1990s/2000s, few people had access to the internet but nowadays just about everyone has access via mobile phones and tablets. This helps awareness as people can easily find stuff (doctors and patients) although they can also find the wrong stuff. Dr Google is not registered or certified (yet) and neither is ChatGPT.
Both of the facts above are a huge advantage in detecting NETs.
I was interested in a report from US earlier this year where it was claimed that the perceived rarity of NET was holding back NET clinical research. I would also claim (forcefully) that it is holding back awareness including within the healthcare community. The report I refer to concluded that NETs are uncommon but definitely not rare. This is a good thing for awareness ….if only those responsible for awareness would change their ‘modus operandi’. I respectfully suggest to anyone involved in awareness to stop spreading rare messages and rare themes, I genuinely believe you are part of the problem, you are working against the progress we need.

What is a NET Specialist?
You can read a useful summary of NET Specialists, NET multidisciplinary teams (MDT) and NET Centres of Excellence (CoE) by clicking this link for the picture below:

I’m a patient – how can a NET Specialist or NET MDT help me or my loved one?
Cancer is complex and NETs are no stranger to this description. Studies have shown that the multidisciplinary approach is the best way to deliver the complex care needed by cancer patients. However, it must be said that it’s also a challenge requiring organisational and cultural changes and must be led by competent healthcare managers who can improve teamwork within their organisations. When this happens, these are the most qualified and experienced “NET Detectives”. The next section will provide you with the “list of lists” but local knowledge from other patients is very useful, and that means joining my group, the largest in the world – see green box down a bit. I have many amateur sleuths in there who can definitely point you in the right direction (but remember they are not doctors)

Disclaimer
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.
Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional.
Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Top 10 Posts & Pages in the last 48 hours (auto updates) (Click the titles to read them)
Thanks for reading.
Personal Facebook. Like this page please.
Blog Facebook. Like this page please.
Awareness Facebook Like this page please.
Sign up for my newsletters – Click Here
My Diagnosis and Treatment History
Check out my online presentations
Check out my WEGO Health Awards
Check out my Glossary of Terms – click here
Please Share this post for Neuroendocrine Cancer awareness and to help another patient

A Spotlight on Neuroendocrine Cancer Syndromes – Carcinoid Syndrome
What is Carcinoid Syndrome? Carcinoid syndrome (CS) is the most frequent hormonal complication accompanying neuroendocrine neoplasms (NENs) and is defined by chronic diarrhoea and/or flushing in the

Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors – PRRT vs Everolimus
I was delighted to see this clinical trial which looks at the efficacy of PRRT (Lu177) vs the efficacy of Everolimus (Afinitor). The latter is

Opinion: Let’s attack Cancer metaphors
Since I started blogging, I’ve read dozens of articles on the subject of ‘cancer metaphors’ and in particular their use in describing cancer experiences with

A review of November 2023 on RonnyAllan.NET – Living with Neuroendocrine Cancer
November is always busier as I help spread awareness for 10th Nov (remembering that every day is 10th Nov on my site!). I also managed

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for Digestive Neuroendocrine Carcinoma
This ENETS guidance paper, developed by a multidisciplinary working group, provides up-to-date and practical advice on the diagnosis and management of digestive neuroendocrine carcinoma, based

Neuroendocrine Cancer – Clinical Esoterica
One of the key awareness messages for Neuroendocrine Cancer is the hormonal syndromes that can often accompany the diagnosis for many people. As it’s a

Neuroendocrine Cancer – The F Words
When I first created my blog in April 2014, I had to find some material to lead up to my 84 mile walk (at the

Laughter is the best medicine
Laughter is important. This is a remastered version of one of my early blog posts. It centred on a ‘get-well’ card I received recuperating in

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastric neuroendocrine tumours (NETs) G1–G3
The ENETS 2023 guideline for gNETs are combined with the guidelines for Duodenal NET (dNET) due to their close relationship in anatomical terms. Gastric neuroendocrine
A cup of tea
I would also mention those who contributed to my “Tea Fund” which resides on PayPal. You don’t need a PayPal account as you can select a card but don’t forget to select the number of units first (i.e. 1 = £4, 2 = £8, 3 = £12, and so on), plus further on, tick a button to NOT create a PayPal account if you don’t need one. Clearly, if you have a PayPal account, the process is much simpler
Through your generosity, I am able to keep my sites running and provide various services for you. I have some ideas for 2023 but they are not detailed enough to make announcements yet.
This screenshot is from every single post on my website and depending on which machine you are using, it will either be top right of the post or at the bottom (my posts are often long, so scroll down!)
Ronny, this is an absolutely outstanding Newsletter and must help and support so many people. I’ve always been proud to call you one of my oldest and best friends; you’re an amazing human being. Thanks for being you.
many thanks George, just applying old skills into new ones. We must meet up soon!
We will Ronny. We are off on holiday from 6th – 13th May, then we can get something in the diary. See you soon.
My journey started with with a swollen lymph node in left groin Oct 2022. The next few months were filled with scans, biopsies and consultations that finally produced a quasi diagnosis of Neuroendocrine Tumors with metastasis and from an unknown source.
My care team from Duke ruled out resection and radiation due to complexity of locations.
Additionally the tests for possible immunotherapies were ruled out due to receptors not lining up to support therapies.
Duke suggested a second opinion and we sought out University of Kentucky.
The good news is they agreed with current path which is now a the more aggressive FOLFIRINOX, of which I’m in my second round.
Scans are scheduled in the coming weeks and encouraged by some noted changes to a very problematic lymphedema left leg.
My question is what if any avenues have you seen if the FOLFIRINOX doesn’t stymie or shrink the tumors?
Thank you in advance for any input.
Steve Stutts
North Carolina
it’s almost impossible for me to respond to that because the grade and differentiation of the tumors (amongst other things) are key in any treatment decisions/recommendations.